Form 8-K - Current report:
SEC Accession No. 0001653477-21-000058
Filing Date
2021-09-16
Accepted
2021-09-16 06:22:26
Documents
15
Period of Report
2021-09-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngvt-20210915.htm   iXBRL 8-K 36890
2 EX-99.1 ex99109152021.htm EX-99.1 12832
6 COMPANY LOGO ingevitylogorgba11.jpg GRAPHIC 146914
7 COMPANY LOGO ngvt-20210915_g1.jpg GRAPHIC 146914
  Complete submission text file 0001653477-21-000058.txt   691100

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngvt-20210915.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngvt-20210915_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngvt-20210915_pre.xml EX-101.PRE 12601
8 EXTRACTED XBRL INSTANCE DOCUMENT ngvt-20210915_htm.xml XML 11181
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 211256926
SIC: 2800 Chemicals & Allied Products